Inhibition of acetylcholinesterase is considered as a promising approach for the treatment of Alzheimer's disease (AD) and for possible therapeutic applications in the treatment of Parkinson's disease, ageing, and myasthenia gravis [26, 27]. Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.